These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37650127)

  • 1. Genome-wide methylation profiling identified methylated KCNA3 and OTOP2 as promising diagnostic markers for esophageal squamous cell carcinoma.
    Bian Y; Gao Y; Lu C; Tian B; Xin L; Lin H; Zhang Y; Zhang X; Zhou S; Wan K; Zhou J; Li Z; Chen H; Wang L
    Chin Med J (Engl); 2024 Jul; 137(14):1724-1735. PubMed ID: 37650127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC).
    Pu W; Wang C; Chen S; Zhao D; Zhou Y; Ma Y; Wang Y; Li C; Huang Z; Jin L; Guo S; Wang J; Wang M
    Clin Epigenetics; 2017; 9():129. PubMed ID: 29270239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic CpG methylation biomarkers identified by methylation array in esophageal squamous cell carcinoma patients.
    Kuo IY; Chang JM; Jiang SS; Chen CH; Chang IS; Sheu BS; Lu PJ; Chang WL; Lai WW; Wang YC
    Int J Med Sci; 2014; 11(8):779-87. PubMed ID: 24936140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide methylation profiling identify hypermethylated HOXL subclass genes as potential markers for esophageal squamous cell carcinoma detection.
    Yu Q; Xia N; Zhao Y; Jin H; Chen R; Ye F; Chen L; Xie Y; Wan K; Zhou J; Zhou D; Lv X
    BMC Med Genomics; 2022 Nov; 15(1):247. PubMed ID: 36447287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A six-CpG panel with DNA methylation biomarkers predicting treatment response of chemoradiation in esophageal squamous cell carcinoma.
    Chang WL; Lai WW; Kuo IY; Lin CY; Lu PJ; Sheu BS; Wang YC
    J Gastroenterol; 2017 Jun; 52(6):705-714. PubMed ID: 27671002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodal analysis of cfDNA methylomes for early detecting esophageal squamous cell carcinoma and precancerous lesions.
    Liu J; Dai L; Wang Q; Li C; Liu Z; Gong T; Xu H; Jia Z; Sun W; Wang X; Lu M; Shang T; Zhao N; Cai J; Li Z; Chen H; Su J; Liu Z
    Nat Commun; 2024 May; 15(1):3700. PubMed ID: 38697989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development and validation of predictive models for esophageal squamous cell carcinoma and its precancerous lesions using terminal motif analysis in circulating cell-free DNA].
    Liu SY; Li ZQ; Dou LZ; Zhang YM; Liu Y; Liu YM; Ke Y; Liu XD; Wu HR; Chu JT; He S; Wang GQ
    Zhonghua Zhong Liu Za Zhi; 2024 Jun; 46(6):549-565. PubMed ID: 38880735
    [No Abstract]   [Full Text] [Related]  

  • 8. Genome-Scale Multimodal Analysis of Cell-Free DNA Whole-Methylome Sequencing for Noninvasive Esophageal Cancer Detection.
    Li Y; Liu B; Zhou X; Yang H; Han T; Hong Y; Wang C; Huang M; Yan S; Li S; Li J; Liu Y; Zhang E; Ni Y; Shen N; Chen W; Huang YS; Wu N
    JCO Precis Oncol; 2024 Jun; 8():e2400111. PubMed ID: 38976830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide screening of DNA methylation associated with lymph node metastasis in esophageal squamous cell carcinoma.
    Nagata H; Kozaki KI; Muramatsu T; Hiramoto H; Tanimoto K; Fujiwara N; Imoto S; Ichikawa D; Otsuji E; Miyano S; Kawano T; Inazawa J
    Oncotarget; 2017 Jun; 8(23):37740-37750. PubMed ID: 28465481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-omic characterization of genome-wide abnormal DNA methylation reveals diagnostic and prognostic markers for esophageal squamous-cell carcinoma.
    Xi Y; Lin Y; Guo W; Wang X; Zhao H; Miao C; Liu W; Liu Y; Liu T; Luo Y; Fan W; Lin A; Chen Y; Sun Y; Ma Y; Niu X; Zhong C; Tan W; Zhou M; Su J; Wu C; Lin D
    Signal Transduct Target Ther; 2022 Feb; 7(1):53. PubMed ID: 35210398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGF5 methylation is a sensitivity marker of esophageal squamous cell carcinoma to definitive chemoradiotherapy.
    Iwabu J; Yamashita S; Takeshima H; Kishino T; Takahashi T; Oda I; Koyanagi K; Igaki H; Tachimori Y; Daiko H; Nakazato H; Nishiyama K; Lee YC; Hanazaki K; Ushijima T
    Sci Rep; 2019 Sep; 9(1):13347. PubMed ID: 31527639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant hypermethylation of RASSF2 in tumors and peripheral blood DNA as a biomarker for malignant progression and poor prognosis of esophageal squamous cell carcinoma.
    Guo W; Dong Z; Cui J; Guo Y; Shen S; Guo X; Kuang G
    Clin Exp Metastasis; 2016 Jan; 33(1):73-85. PubMed ID: 26482475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant DNA methylation of PAX1, SOX1 and ZNF582 genes as potential biomarkers for esophageal squamous cell carcinoma.
    Tang L; Liou YL; Wan ZR; Tang J; Zhou Y; Zhuang W; Wang G
    Biomed Pharmacother; 2019 Dec; 120():109488. PubMed ID: 31629253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma cell-free DNA 5-hydroxymethylcytosine and whole-genome sequencing signatures for early detection of esophageal cancer.
    Lu D; Wu X; Wu W; Wu S; Li H; Zhang Y; Yan X; Zhai J; Dong X; Feng S; Zhang X; Sun F; Wang S; Cai K
    Cell Death Dis; 2023 Dec; 14(12):843. PubMed ID: 38114477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of using P16 methylation as a cytologic marker for esophageal squamous cell carcinoma screening: A pilot study.
    Fan Z; Qin Y; Zhou J; Chen R; Gu J; Li M; Zhou J; Li X; Lin D; Wang J; Deng D; Wei W
    Cancer Med; 2022 Nov; 11(21):4033-4042. PubMed ID: 35352503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A microRNA-based liquid biopsy signature for the early detection of esophageal squamous cell carcinoma: a retrospective, prospective and multicenter study.
    Miyoshi J; Zhu Z; Luo A; Toden S; Zhou X; Izumi D; Kanda M; Takayama T; Parker IM; Wang M; Gao F; Zaidi AH; Baba H; Kodera Y; Cui Y; Wang X; Liu Z; Goel A
    Mol Cancer; 2022 Feb; 21(1):44. PubMed ID: 35148754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a DNA methylome profile of esophageal squamous cell carcinoma and potential plasma epigenetic biomarkers for early diagnosis.
    Li X; Zhou F; Jiang C; Wang Y; Lu Y; Yang F; Wang N; Yang H; Zheng Y; Zhang J
    PLoS One; 2014; 9(7):e103162. PubMed ID: 25050929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive diagnosis of esophageal cancer by a simplified circulating cell-free DNA methylation assay targeting OTOP2 and KCNA3: a double-blinded, multicenter, prospective study.
    Bian Y; Gao Y; Lin H; Sun C; Wang W; Sun S; Li X; Feng Z; Ren J; Chen H; Lu C; Xu J; Zhou J; Wan K; Xin L; Li Z; Wang L
    J Hematol Oncol; 2024 Jun; 17(1):47. PubMed ID: 38890756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide profiling of DNA methylation and gene expression in esophageal squamous cell carcinoma.
    Chen C; Peng H; Huang X; Zhao M; Li Z; Yin N; Wang X; Yu F; Yin B; Yuan Y; Lu Q
    Oncotarget; 2016 Jan; 7(4):4507-21. PubMed ID: 26683359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-Wide DNA Methylation Profiling of Esophageal Squamous Cell Carcinoma from Global High-Incidence Regions Identifies Crucial Genes and Potential Cancer Markers.
    Talukdar FR; Soares Lima SC; Khoueiry R; Laskar RS; Cuenin C; Sorroche BP; Boisson AC; Abedi-Ardekani B; Carreira C; Menya D; Dzamalala CP; Assefa M; Aseffa A; Miranda-Gonçalves V; Jerónimo C; Henrique RM; Shakeri R; Malekzadeh R; Gasmelseed N; Ellaithi M; Gangane N; Middleton DRS; Le Calvez-Kelm F; Ghantous A; Roux ML; Schüz J; McCormack V; Parker MI; Pinto LFR; Herceg Z
    Cancer Res; 2021 May; 81(10):2612-2624. PubMed ID: 33741694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.